Redhill Seeks Migraine, Oncology Partners After Nasdaq Listing – Bloomberg
|
Redhill Seeks Migraine, Oncology Partners After Nasdaq Listing
Bloomberg Redhill, which takes existing drugs and patents them under improved formulations, listed in December on the Nasdaq. Investors include Dan Suesskind, a Redhill board member who is also former Chief Financial Officer at Teva Pharmaceutical Industries Ltd. |
